2023-07-14 03:31:44 ET
-
Genome-editing biopharmaceutical company Caribou Biosciences ( NASDAQ: CRBU ) has upsized underwritten public offering of 19.23 million shares at a public offering price of $6.50 per share.
-
Gross proceeds from the offering are expected to be approximately $125 million.
-
The shares offering was increased from previously announced $100 million to $125 million.
-
All of the shares to be sold in the offering will be offered by Caribou.
-
Underwriters have a 30-day option to purchase up to an additional ~2.88 million shares of common stock at the public offering price.
-
The offering is expected to close on July 18, 2023.
-
More on Caribou Biosciences
-
Caribou CAR-T lymphoma cell therapy does well in phase 1 trial
- Caribou: Potential To Improve Response Duration With Higher Dose Level
- Caribou Biosciences: Like Watching Paint Dry
-
Caribou Biosciences commences $100M public offering of shares
For further details see:
Caribou Biosciences prices upsized stock offering of $125M at $6.50